Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James C. Mullen currently holds 2,828 shares of Editas Medicine, Inc. (EDIT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James C. Mullen has been a net seller of EDIT stock. They have purchased $4.7M and sold $111.0M worth of shares.
James C. Mullen's most recent insider trade was on May 22, 2024, when they sold 339 shares at $0.00 per share.
James C. Mullen serves as Executive at Editas Medicine, Inc. (EDIT). They have executed 317 insider transactions totaling $115.7M over their tenure at the company.
James C. Mullen holds the position of Executive at Editas Medicine, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 22 years and currently hold a stake valued at $0.
James C. Mullen has shown a selling trading pattern, with $4.7M in total purchases and $111.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James C. Mullen was on Aug 29, 2017, when they sold $91.5M worth of PTHN shares. This transaction involved 2,615,089 shares at $35.00 per share.
James C. Mullen currently owns 2,828 shares of Editas Medicine, Inc. (EDIT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James C. Mullen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James C. Mullen has 317 Form 4 filings on record as an insider at Editas Medicine, Inc..
Set alerts for James C. Mullen and 40,000+ other insiders.